Farxiga vs Invokana
A side-by-side look at two diabetes medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Farxiga | US Invokana |
|---|---|---|
| Generic name | dapagliflozin Unverified catalogue summary (Generic name) for Farxiga in US; not checked against current local product information. | canagliflozin Unverified catalogue summary (Generic name) for Invokana in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Farxiga in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Invokana in US; not checked against current local product information. |
| Treats | Type 2 diabetes, heart failure, chronic kidney disease Unverified catalogue summary (Treats) for Farxiga in US; not checked against current local product information. | Type 2 diabetes, diabetic kidney disease Unverified catalogue summary (Treats) for Invokana in US; not checked against current local product information. |
| Category | Diabetes Unverified catalogue summary (Category) for Farxiga in US; not checked against current local product information. | Diabetes Unverified catalogue summary (Category) for Invokana in US; not checked against current local product information. |
| Manufacturer | AstraZeneca Unverified catalogue summary (Manufacturer) for Farxiga in US; not checked against current local product information. | Janssen Pharmaceuticals, Inc. (manufactured for) Unverified catalogue summary (Manufacturer) for Invokana in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Farxiga in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Invokana in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Farxiga in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Invokana in US; not checked against current local product information. |
| Est. TV ad spend | $220M | $110M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Farxiga in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Invokana in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Farxiga or Invokana better?
This directory does not compare clinical effectiveness or safety. Listing Farxiga and Invokana together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Farxiga and Invokana?
The table shows catalogue identification and estimated advertising information for Farxiga and Invokana, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Farxiga has the larger estimated TV advertising budget of the two.